Keyphrases
3-group
16%
Activated Partial Thromboplastin Time (aPTT)
16%
Adaptive Immune Response
16%
Antiphospholipid Antibodies
16%
Antithrombin
16%
Brain Hemodynamics
16%
C Protein
16%
C3-C4
16%
Central Nervous System Demyelinating Diseases
16%
Cerebral Blood Flow
50%
Cerebral Blood Volume
33%
Cerebral Hypoperfusion
100%
Clinical Features
16%
Clinical Trial Registry
16%
Coagulation
100%
Coagulation Status
16%
Complement Activation
100%
Complement C3
16%
Complement Factors
16%
Complement System
16%
Complete Blood Count
16%
D-dimer
16%
Dynamic Susceptibility Contrast Enhanced MRI
16%
Effector Mechanisms
16%
Endothelial Damage
16%
Endothelial Protein C Receptor
16%
Fibrinogen
16%
Healthy Controls
16%
Hemodynamic Changes
16%
Imaging Biomarkers
16%
Imaging Target
16%
Immune Pathogenesis
16%
Immunothrombosis
16%
Inflammation
16%
Inflammatory Immune Response
16%
Inflammatory Pathogenesis
16%
Innate Immunity
16%
Lesion number
16%
Lesion Volume
16%
Lupus Anticoagulant
16%
Mean Transit Time
33%
MicroRNA Microarray
16%
MS Patients
16%
Multiple Sclerosis
33%
Multiple Sclerosis Pathogenesis
16%
Multiple Sclerosis Relapse
16%
Multiple Sclerosis Treatment
50%
Patient's Will
16%
Perfusion
16%
Plasma Parameters
16%
Platelet Activation
16%
Prospective Controlled Study
16%
Relapsing-remitting multiple Sclerosis
100%
Remission
50%
Serological Assay
16%
Soluble Markers
16%
Specific Intent
16%
Statistical Analysis
16%
T-test
16%
Therapeutic Strategies
16%
Thrombomodulin
16%
Viral
16%
Viral Infection
16%
Von Willebrand Factor
16%
Immunology and Microbiology
Adaptive Immune System
16%
Antiphospholipid Antibody
16%
Blood Cell Count
16%
Blood Level
16%
Brain Blood Flow
50%
Central Nervous System
16%
Clinically Isolated Syndrome
16%
Complement Activation
100%
Complement Component 3
16%
Complement Factor
16%
Complement System
16%
Dynamic Susceptibility Contrast
16%
Endothelial Protein C Receptor
16%
Fibrinogen
16%
Hemodynamic
16%
Infection
16%
Innate Immune System
16%
Lupus Anticoagulant
16%
Magnetic Resonance Imaging
50%
Multiple Sclerosis
100%
Nonspecific Defense
16%
Perfusion
100%
Relapsing Remitting Multiple Sclerosis
100%
Thrombocyte Activation
16%
Thrombomodulin
16%
Viral Disease
16%
Medicine and Dentistry
Adaptive Immunity
12%
Analysis of Variance
12%
Antiphospholipid Antibody
12%
Antithrombin
12%
Biological Marker
12%
Blood Clotting Factor 8
12%
Brain Blood Flow
37%
Central Nervous System
12%
Clinical Feature
12%
Clinical Trial
12%
Clinically Isolated Syndrome
12%
Complement Activation
100%
Complement Component C3
12%
Complement Component C4a
12%
Complement Factor
12%
Complement System
12%
D-Dimer
12%
Dynamic Susceptibility Contrast
12%
Endothelial Protein C Receptor
12%
Factor X
12%
Fibrinogen
12%
Hemodynamic
12%
Infection
12%
Innate Immunity
12%
Lupus Anticoagulant
12%
Magnetic Resonance Imaging
37%
microRNA
12%
Multiple Sclerosis
100%
Nonspecific Defense
12%
Protein C
25%
Protein S
12%
Prothrombin
12%
Student T Test
12%
Thrombocyte Activation
12%
Thrombomodulin
12%
Virus Infection
12%
Von Willebrand Factor
12%